HI-TORQUE BALANCE MIDDLEWEIGHT ELITE GUIDE WIRE
Report
- Report Number
- 2024168-2013-04495
- Event Type
- Malfunction
- Date Received
- July 18, 2013
- Date of Event
- June 24, 2013
- Report Date
- June 24, 2013
- Manufacturer
- AV-TEMECULA-CT
- Product Code
- DQX
- PMA / PMN Number
- K103101
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
(B)(4). THE DEVICE WAS RECEIVED. INVESTIGATION IS NOT YET COMPLETE. A FOLLOW UP REPORT WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION.
(B)(4). EVALUATION SUMMARY: THE DEVICE WAS RETURNED FOR ANALYSIS. THE SEPARATION WAS ABLE TO BE CONFIRMED. BASED ON A VISUAL INSPECTION AND SCANNING ELECTRON MICROSCOPY (SEM) IMAGING OF THE RETURNED DEVICE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. A REVIEW OF THE LOT HISTORY RECORD REVEALED NO NON-CONFORMANCES THAT WOULD HAVE CONTRIBUTED TO THE REPORTED EVENT. THE RESULTS OF THE QUERY OF SIMILAR INCIDENTS IN THE COMPLAINT HANDLING DATABASE FOR THIS LOT DID NOT INDICATE A MANUFACTURING ISSUE. BASED ON THE REVIEWED INFORMATION, NO PRODUCT DEFICIENCY WAS IDENTIFIED.
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN UN-SPECIFIED LESION IN THE PERIPHERAL. THE BALANCE MIDDLEWEIGHT (BMW) ELITE GUIDE WIRE WAS ADVANCED WITHOUT ISSUE. A NON-ABBOTT EMBOLIC PROTECTION DEVICE WAS THEN ADVANCED, AND THE BMW ELITE GUIDE WIRE WAS REMOVED. AFTER REMOVAL, IT WAS NOTED THAT A PORTION OF THE GUIDE WIRE HAD SEPARATED. THERE WAS NO RESISTANCE NOTED DURING REMOVAL OF THE GUIDE WIRE. THE SEPARATED PORTION WAS REMOVED WITH THE EMBOLIC PROTECTION DEVICE. A NEW GUIDE WIRE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 333150 | HI-TORQUE BALANCE MIDDLEWEIGHT ELITE GUIDE WIRE | GUIDE WIRE | DQX | AV-TEMECULA-CT | 2081001 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 73 YR | EMBOLIC PROTECTION: SPIDER |